|
CR1101a : Cervical cancer tissue array with normal adjacent cervical tissue (NAT), including TNM, clinical stage (AJCC 8th edition) and pathology grade, 110 cases/110 cores (core size 1.5mm), replacing CR1101
Description
| Microarray Panel |
Cervical carcinoma with NAT cervical tissue microarray, containing 95 cases squamous cell carcinoma，3 adenocarcinoma, 2 endometrioid adenocarcinoma, 10 adjacent normal cervical tissue, single cores per case |
| Cores |
110 |
|
| Cases |
110 |
| Row number |
11 |
| Column number |
10 |
| Core Diameter (mm) |
1.5 |
| Thickness (µm) |
5 |
| Quality Control |
H&E and IHC confirmed |
| Tissue Array Type |
FFPE |
| Species |
Human |
| Applications |
Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. |
| Notes |
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Find overlapping cases with this tissue array:
- Product Code: CR1101a
- Availability: In Stock
|
Tags:
With normal control,
Stage (TNM),
Single core per case
- Malignant tumor,
- Malignant tumor (stage IB1),
- Malignant tumor (stage IB2),
- Malignant tumor (stage IIA1),
- Malignant tumor (stage IIA2),
- Malignant tumor (stage IIB),
- Malignant tumor (stage III),
- Malignant tumor (stage IIIA),
- NAT